Article Name Hospital & Healthcare
Abbott Receives FDA Approval for World's First Dual Chamber Leadless Pacemaker
Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the AVEIR™ dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacing system that treats people with abnormal or slow heart rhythms. With more than 80% of people who need a pacemaker requiring pacing in two chambers of the heart (both the right atrium and right ventricle), the approval significantly increases access to leadless pacing for millions of people across the U.S.[i]
06th July, 2023
Drs.OnCalls is entering the Indian market in a strategic expansion bid
US Telemedicine Platform “Drs.OnCalls” enters India; the first app to provide real-time telemedicine consultation with world-renowned doctors globally 24x7
06th July, 2023
AOI Revolutionizes Cancer Care in Telangana with AI-Powered Ethos Radiotherapy, Becomes Advanced Cancer Centre
Inaugurated by the Minister for Finance, Health, Medical & Family Welfare, Government of Telangana
05th July, 2023
RICH Launches Month-Long Session on Medical Device and IVD Commercialization Journey
Research and Innovation Circle of Hyderabad (RICH) launched the month-long awareness and hands-on session for students, aspiring entrepreneurs, researchers, start-ups, MSMEs, and SMEs/industry players on the commercialization of Category A, B, C, and D medical devices and in-vitro diagnostics (IVDs
04th July, 2023
Medtronic Welcomes ESH Guidelines on Renal Denervation for Hypertension Treatment
Medtronic is excited by the updated European Hypertension Society (ESH) guidelines that highlight the role of renal denervation (RDN) as part of the hypertension care pathway. The guidelines were announced at the ESH 32nd Annual Meeting and simultaneously published in the Journal of Hypertension.
04th July, 2023
Survey Reveals 65% of Surgeons aren't Happy with the Current Medical Infrastructure in India
Work-Life Balance Challenges Take Toll as 48% of Surgeons Struggle with Burnout
03rd July, 2023
BD India's Pledge for Safety Initiative Launched with a 'Safety Flame' March from Ruby Hall Clinic
To enhance awareness around the importance of safety protocols, practices, and technologies to deliver optimum Patient and clinical outcomes as well as enable knowledge-sharing of best practices around this key area, BD (Becton, Dickinson, and Company) recently organized the ‘Pledge for Safety' - Clinical Leaders Forum.
30th June, 2023
Empowering Patients in Cataract Surgery: Choosing the Right Lens for Your Vision Needs
Collaborative Decision-Making Process between Patients and Surgeons
30th June, 2023
Kauvery Hospital, Chennai Introduces Next-Generation AI-Based Ultreon Coronary Imaging System
Kauvery Heart Institute, the center of excellence in comprehensive cardiac services at Kauvery Hospital - Radial Road, Kovilambakkam, proudly announces the launch of the latest AI-based Ultreon Coronary Imaging system. By acquiring this ground-breaking technology, Kauvery Hospital - Radial Road positions itself as the leader in Cardiac Sciences by being the first hospital in Tamil Nadu to acquire a state-of-the-art OCT system, empowering cardiologists with advanced capabilities for precise coronary analysis and guiding complex angioplasty and stenting procedures.
30th June, 2023
Core Sound Imaging's Studycast Integration Program impacts hospital workflows
[Health System in New York City pilots the Studycast Integration Program using Us2.ai's complete echo AI tools for automating echo measurements. Core Sound Imaging's Studycast Integration Program has been designed to deliver a frictionless workflow for AI tools.]
29th June, 2023
APAC Cardiovascular Disease Alliance to tackle heart disease in Asia
Building interdisciplinary, multisectoral partnerships to unite CVD action across borders
28th June, 2023
HSS Surgeon Performs World's First Stemmed Elliptical Head Prosthesis Implant for Shoulder Replacement
System Allows Conversion to Reverse Shoulder Replacement Prosthesis
28th June, 2023
Roche Gets FDA Clearance for Additional Alzheimer's CSF Assays, Enhancing Diagnosis and Treatment Decisions
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its Elecsys® beta-Amyloid (1-42) CSF II (Abeta42) and Elecsys® Total-Tau CSF assays (tTau) have received U.S. Food and Drug Administration (FDA) 510(k) clearance. The Elecsys AD CSF Abeta42 and tTau assays (used as a tTau/Abeta42 ratio) measure two biomarkers of Alzheimer's pathology, beta-amyloid and tau proteins, in adults ages 55 and older being evaluated for the disease.
28th June, 2023
INVO Receives 510(k) FDA Clearance for Expanded Use of the INVOcell Device
INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the intravaginal culture ("IVC") procedure it enables, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to expand the labeling on the INVOcell device and its indication for use to provide for a 5-day incubation period. The data supporting the expanded 5-day incubation clearance demonstrated improved patient outcomes.
28th June, 2023
Eko Health Launches CORE 500™ Digital Stethoscope with Heart Disease Detection AI and Advanced Features
Next-generation FDA-cleared medical device brings non-invasive heart and lung disease detection to healthcare professionals at the point of care
28th June, 2023
Manipal Hospitals enhances use of high-end minimally invasive procedures
Manipal Hospitals and Queen Elizabeth University Hospital – Interventional Radiology departments ink partnership
17th April, 2023
Aurobindo Pharma injects Rs 80 Cr to build Oncology Block for MNJ Hospital in Hyderabad
State-of-the-art facility span over 2,32,000 square feet
17th April, 2023
Yashoda Hospital, Ghaziabad unveils new department for robotic surgery and AI
Union Health Minister inaugurates the department
12th April, 2023
Medtech Special
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer